Biomoda raises $2M for lung cancer diagnostic test

05/10/2010 | American City Business Journals

Biomoda has secured $2 million in funding from three hedge funds to conduct further clinical trials of a diagnostic test to detect lung cancer. "Proceeds from the financing will allow us to continue our clinical trials, submit our findings to the FDA for clearance as a Class III medical device and begin commercialization," said John Cousins, Biomoda's president and CEO.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC